Drugs / AZD5985
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00967356 | Aug → Nov 2009 | — | AstraZeneca | Terminated | No outcome recorded |
| Phase 1 | NCT00799331 | Nov 2008 → Feb 2009 | — | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD5985 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00967356 ↗ |
| Route | Oral | “increasing oral doses of AZD5985” NCT00799331 ↗ |